Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Minoxidil nanoparticles improve hair growth more effectively than regular minoxidil.

MVP treatment is effective and safe for recurrent breast cancer.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

DFMO may help control hair growth and treat cancer.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.